Literature DB >> 15581339

Serum leptin and myocardial infarction in hypertension.

Susanna M Wallerstedt1, Anna-Lena Eriksson, Anders Niklason, Claes Ohlsson, Thomas Hedner.   

Abstract

The adipose tissue-derived hormone leptin is among the physiologic processes involved in cardiovascular regulation. The aim of the present study was to elucidate if serum leptin may predict cardiovascular risk, particularly myocardial infarction (MI), in hypertensive men and women. In a prospective study cohort of hypertensive men and women, serum leptin was compared in 171 patients with MI and in 342 matched controls. The mean serum concentration of leptin was 25.1 +/- 20.0 ng/ml in the MI patients and 20.0 +/- 16.6 ng/ml in the controls (p = 0.007). The association between serum leptin and MI was independent of traditional risk factors. Leptin concentrations were higher in women than in men. In women, serum leptin was the most important predictor of MI. The present study indicates that serum leptin is associated with MI in a hypertensive population. Leptin concentrations may be of practical importance when estimating the risk of MI, especially in women, where leptin was found to be the most important predictor for MI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581339     DOI: 10.1080/08037050410021405

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  18 in total

Review 1.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 2.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

3.  Leptinemia is Associated With Peripheral Artery Disease.

Authors:  Greg J Zahner; Joel L Ramirez; Kimberly A Spaulding; Sukaynah A Khetani; Warren J Gasper; Carl Grunfeld; Nancy K Hills; Anne L Schafer; S Marlene Grenon
Journal:  J Surg Res       Date:  2019-02-06       Impact factor: 2.192

4.  Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.

Authors:  Yuji Takahashi; Mamoru Satoh; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  Heart Vessels       Date:  2011-06-04       Impact factor: 2.037

5.  Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.

Authors:  Ivy A Ku; Ramin Farzaneh-Far; Eric Vittinghoff; Mary H Zhang; Beeya Na; Mary A Whooley
Journal:  Atherosclerosis       Date:  2010-12-02       Impact factor: 5.162

Review 6.  Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Authors:  José J Fuster; Noriyuki Ouchi; Noyan Gokce; Kenneth Walsh
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

7.  Novel locus for fibrinogen in 3' region of LEPR gene in island population of Vis (Croatia).

Authors:  Željka Tomas; Matea Zajc Petranović; Tatjana Škarić-Jurić; Ana Barešić; Marijana Peričić Salihović; Nina Smolej Narančić
Journal:  J Hum Genet       Date:  2014-10-09       Impact factor: 3.172

8.  Expression of the leptin receptor in different types of vascular lesions.

Authors:  Marco R Schroeter; Jacob Schneiderman; Bettina Schumann; Roland Glückermann; Petros Grimmas; Arnd B Buchwald; Theodor Tirilomis; Friedrich A Schöndube; Stavros V Konstantinides; Katrin Schäfer
Journal:  Histochem Cell Biol       Date:  2007-08-07       Impact factor: 4.304

9.  Human soluble leptin receptor concentration in healthy offspring of hypertensive parents.

Authors:  Dimitris P Papadopoulos; Thomas K Makris; Maria Poulakou; Urania G Papazachou; Antonios N Hatzizacharias; Despina N Perrea; Vassilios E Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

10.  The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.

Authors:  Omar M Kaisar; David W Johnson; Judith B Prins; Nicole Isbel
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.